Xiao-Jun Lin
Overview
Explore the profile of Xiao-Jun Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Chen J, Lin X, Zhou Q, Shi M, Li S, Lao X
Chin J Cancer
. 2016 Mar;
35:28.
PMID: 26992891
Background: It remains unclear what the antiviral therapy affects disease-free survival (DFS) and overall survival (OS) of patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) at different tumor stages...
22.
Chen J, Lao X, Lin X, Xu L, Cui B, Wang J, et al.
Medicine (Baltimore)
. 2016 Feb;
95(5):e2665.
PMID: 26844496
Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the...
23.
Lin X, Li Q, Lao X, Yang H, Li S
BMC Cancer
. 2015 Oct;
15:707.
PMID: 26470869
Background: The aim of this study was to determine the clinical benefit of transhepatic arterial chemoembolization (TACE) with or without recombinant human adenovirus type 5 (H101) administration for the treatment...
24.
Zhou Z, Zheng X, Zhou Q, Shi M, Zhang Y, Guo R, et al.
Chin J Cancer
. 2015 Jun;
34(5):205-16.
PMID: 26058595
Introduction: Most hepatocellular carcinomas (HCC) develop in a background of underlying liver disease including chronic hepatitis B. However, the effect of antiviral therapy on the long-term outcome of patients with...
25.
Zhang M, Li S, Huang G, Lin G, Shuang Z, Lao X, et al.
BMC Cancer
. 2015 Apr;
15:64.
PMID: 25880914
Background: The clinical significance of microRNAs (miRNAs) in intrahepatic cholangiocarcinoma (ICC) is unclear. The objective of this study is to examine the miRNA expression profiles and identify a miRNA signature...
26.
Xu L, Peng Z, Chen M, Shi M, Zhang Y, Guo R, et al.
J Hepatol
. 2015 Mar;
63(1):122-30.
PMID: 25725438
Background & Aims: To establish an effective prognostic nomogram for patients with unresectable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). Methods: The nomogram was constructed based on data obtained from...
27.
Dai Q, Gu H, Ye S, Zhang Y, Lin X, Lau W, et al.
Mol Clin Oncol
. 2014 Oct;
2(6):1047-1054.
PMID: 25279196
This study was conducted to compare long-term survival between patients with unresectable infiltrating hepatocellular carcinoma (HCC) who were treated with transarterial chemoembolization (TACE) and those who received conservative treatment (best...
28.
Shen J, Lin X, Cui B, Chi P, Zeng Q, Zhao Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
. 2014 Mar;
25(12):743-8.
PMID: 24620386
Objective: To observe the protective effect of Xuebijing injection pretreatment on hepatic ischemia reperfusion (I/R) injury and coagulopathy in liver cancer patients undergoing excision of hepatic cancer after occlusion of...
29.
Lin X, Cai X, Ye J, Tang C, Li W, He Z
Zhonghua Yi Xue Za Zhi
. 2013 Dec;
93(29):2305-8.
PMID: 24300151
Objective: To explore the significance and evaluate the early structural erosion through the expressions of Th17 cells in peripheral blood of patients with rheumatoid arthritis (RA) in clinical remission. Methods:...
30.
Peng Z, Liu F, Ye S, Xu L, Zhang Y, Liang H, et al.
Cancer
. 2013 Aug;
119(21):3812-20.
PMID: 23922119
Background: This study retrospectively compared the safety and efficacy of percutaneous radiofrequency ablation (RFA) with open hepatic resection (HR) in elderly patients (age > 65 years) with very early or...